Frontlight ResearchEarly access
CompletedNo phase
Long-Term Outcomes of Hypopituitarism Following Gamma Knife Radiosurgery for Pituitary Adenomas
Key facts
- Who runs it
- Al-Azhar University
- Where
- Egypt1 site in 1 countryChoose a country to see its sites
- Trial code
- Status
- Completed
- People taking part
- 137 people enrolled
- Started
- 1 Jan 2019
- Ended
- 1 Jan 2025
- Type of study
- Observational
- Treatments tested
- Gamma Knife Radiosurgery
- Record updated
- 11 June 2025
Who can take part
- Age
- 18 years and older
- Sex
- Women and men
- Healthy volunteers
- Cannot take part
The registry criteria, word for word
Show all 7 criteriaShow less
Who can take part
- Age ≥18 years
- Both sexes
- Patients treated with gamma knife radiosurgery (GKRS)
Who cannot take part
- Patients who had undergone previous radiation therapy
- Pituitary insufficiency which presents before gamma knife radiosurgery (GKRS)
- Patients with inadequate endocrine follow-up (<12 months)
- Patients without visible glands
This trial has no sites in United States.
It has sites in one country. Choose a country to see its sites.
About the trial
What the trial wants to find out
This study aims to assess long-term outcomes of hypopituitarism following gamma knife radiosurgery (GKRS) for pituitary adenomas.
The group in the trial
- Pituitary Adenomas group
Patients received gamma knife radiosurgery (GKRS) treatment for pituitary adenomas.
Treatment: Gamma Knife Radiosurgery
Data and sources
- Registry record
- Listed on ClinicalTrials.gov.
- Record updated
- 11 June 2025